Pharmaxis Ltd Health Care
Biotech Cancer Healthcare Pharmaceuticals

$0.049 0.007 (16.67%)

High $0.05	Low $0.04	Trades 74	Turnover $48,318	Volume 1,094,468
30 June 2023 at 4:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code PXS	Name Pharmaxis Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Pharmaceuticals	GIC Sub Industry Pharmaceuticals
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 722,614,016	Shares Floated 329,310,561	Held by Insiders 17.326%	Held by Institutions 37.479%

Directors & Officers

Name & Education	Position
Mr. Gary Jonathan Phillips BPharm, MBA	CEO, MD & Director
Mr. David Morris McGarvey BA, CA, CPA	CFO & Company Sec.
Dr. Wolfgang G. Jarolimek B.Sc. Ph.D., Ph.D.	Head of Drug Discovery
Ms. Kristen Morgan B.Sc., BSc, MMedSc, PGDipBusAdmin	Head of Medical & Regulatory Affairs - Alliance Management
Dr. Jana Baskar	Chief Medical Officer
Mr. Cameron David Billingsley	Gen. Counsel
Dr. Dieter Hamprecht	Head of Chemistry for Drug Discovery

PXS Historic Dividends

Date	Amount
We found no dividends on record for PXS.

End of Day Prices

Date	Close	Volume	Change
08-Feb	$0.02	2,313,063	0.00 (0.00%)
07-Feb	$0.02	88,549	0.00 (0.00%)
06-Feb	$0.02	185,399	0.00 (0.00%)
05-Feb	$0.02	527,551	0.00 (0.00%)
02-Feb	$0.02	762,847	+0.00 (5.00%)
01-Feb	$0.02	1,829,174	+0.00 (5.26%)
31-Jan	$0.02	3,202,962	0.00 (0.00%)
30-Jan	$0.02	1,188,895	+0.00 (11.76%)
29-Jan	$0.02	637,140	0.00 (0.00%)
25-Jan	$0.02	788,861	0.00 (0.00%)
24-Jan	$0.02	881,505	0.00 (5.56%)
23-Jan	$0.02	636,016	+0.00 (5.88%)
22-Jan	$0.02	78,661,135	0.00 (0.00%)
19-Jan	$0.02	52,375	0.00 (0.00%)
18-Jan	$0.02	1,295,388	0.00 (10.53%)
4 up, 2 down, and 9 flat days

Market Cap (9-Feb) $19,510,578	EBITDA -	PE 20.45	Book Value $0.01
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.02	Profit Margin N/A
Operating Margin -742.67%	ROA 48.68%	ROE 237.24%	Revenue (FY) $11,895,000
Revenue per Share $0.02	Gross Profit (FY) $7,770,000	Q' YOY Revenue Growth 90.4%	Q' YOY Earnings Growth -

Pharmaxis Ltd Health Care
Biotech Cancer Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (September 2023)

Directors & Officers

PXS Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Pharmaxis Ltd Health Care Biotech Cancer Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (September 2023)

Directors & Officers

PXS Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Pharmaxis Ltd Health Care
Biotech Cancer Healthcare Pharmaceuticals